In a 2017 study published in Scientific Reports, researchers exposed rats to human-relevant levels of E171 to examine the effects of intestinal inflammation and carcinogenesis. They saw that “a 100-day E171 treatment promoted colon microinflammation and initiated preneoplastic lesions while also fostering the growth of aberrant crypt foci in a chemically induced carcinogenesis model.” They continued: “Stimulation of immune cells isolated from Peyer’s Patches [which are clusters of lymphoid follicles found in the intestine] showed a decrease in Thelper (Th)-1 IFN-γ secretion, while splenic Th1/Th17 inflammatory responses sharply increased,” researchers wrote. “A 100-day titanium dioxide treatment promoted colon microinflammation and initiated preneoplastic lesions.” The scientists concluded: “These data should be considered for risk assessments of the susceptibility to Th17-driven autoimmune diseases and to colorectal cancer in humans exposed to TiO2 from dietary sources.”

Titanium dioxide (TiO₂) is a multifunctional semiconductor that exists in three crystalline forms: anatase, rutile, and brookite. Owing to an appropriate combination of physical and chemical properties, environmental compatibility, and low production cost, polycrystalline TiO₂ has found a large variety of applications and is considered to be a promising material for future technologies. One of the most distinctive physical properties of this material is its high photocatalytic activity (Nam et al., 2019); however, more recently it has attracted growing interest because of its resistive switching abilities (Yang et al., 2008).

Another challenge facing TiO2 industry suppliers is the increasing environmental regulations and sustainability requirements. The production of TiO2 can have environmental impacts, such as energy consumption and waste generation. Suppliers must invest in sustainable practices and technologies to minimize their environmental footprint and meet regulatory requirements.